Investigational PSMA-Targeted Treatment Demonstrates Antitumor Activity in mCRPC

Other reported AEs included fatigue, nausea, vomiting, anemia, headache, back pain, tachycardia, constipation, and decreased appetite. “HPN424 …
Source: back pain